Newsletter | May 9, 2025

05.09.25 -- CTTI Survey Identifies Why Many PIs Drop Out After One Trial

SPONSOR

DIA 2025 Global Annual Meeting

In a time of rapid change, no single discipline can move forward alone. DIA 2025 Global Annual Meeting (DIA 2025) brings together regulatory, clinical, safety, and operational leaders to confront shared challenges and design smarter, faster, more connected solutions. From real-time FDA insights to global regulatory and multi-disciplinary collaboration, DIA 2025 is where silos break down and progress accelerates. Join the conversation that’s shaping what’s next!

CLINICAL DATA MANAGEMENT & ANALYTICS

Unsure About The New ICH Guidelines? TransCelerate Debuts 13 Tools To Help

Guest Column | A conversation with Tashan Mistree, TransCelerate BioPharma

TransCelerate BioPharma's Tashan Mistree discusses 13 new tools created alongside the Association of Clinical Research Organizations (ACRO) to support ICH GCP E6(R3) adoption.

6 Key Ways Real-World Data Is Accelerating Breast Cancer Therapies

Application Note | Quest Diagnostics

Real-world data (RWD) is increasingly vital for advancing breast cancer research, and leveraging TA datasets allows researchers and clinicians to address pressing challenges.

The PPD Clinical Trial Forecasting Suite

Brochure | Thermo Fisher Scientific

An advanced AI-powered platform designed to revolutionize clinical trial planning and execution leverages deep learning and proprietary performance data to deliver highly accurate, real-time forecasts.

A QMS Software That Enhances Operational Excellence

Product | Ideagen

Ideagen Quality Management is a modular SaaS solution designed with the needs of quality managers in mind.

TRIAL MONITORING

CTTI Survey Identifies Why Many PIs Drop Out After One Trial

Video | By Clinical Leader Live

Morgan Hanger of CTTI discusses their survey of 201 PIs in FDA-regulated drug trials that indicated over half (108) participated only once in a trial, citing time constraints, workload, safety reporting, and financial burdens were why they did not continue. Despite these challenges, 44% wanted to continue but lacked opportunities, suggesting a disconnect in trial recruitment. 

Remote Patient Monitoring Using Mobile Health Technology

White Paper | By Dominique G. Stuijt, Eva EM van Doeveren, Milan Kos, Marijn Eversdijk, et al., CHDR

This study investigates the attitudes of cancer patients towards the adoption of mHealth technologies, including applications and wearable devices, for monitoring purposes during or after their treatment.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Friday edition of the Clinical Leader newsletter, focusing on Clinical Data Management & Analytics and Trial Monitoring. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: